The Trump Presidency Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : The Trump Presidency

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

koan

rdkflorida2

Ted Beneke

To: i-node who wrote (314014)	12/23/2024 10:40:08 AM
From: puborectalis	3 Recommendations Read Replies (1) of 361803

Controversial study of hydroxychloroquine for COVID-19 treatment retracted A controversial COVID-19 treatment study that influenced early pandemic drug policy has been retracted by the International Journal of Antimicrobial Agents, more than four-and-a-half years after its publication. The paper, which promoted hydroxychloroquine (HCQ) as a potential treatment for COVID-19, marks the 28th retraction for its prominent co-author,

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next